The primary clinical and operational benefits of AVITA Medical's RCEL platform center around its proprietary RECELL system, which enables clinicians to prepare a suspension of regenerative autologous cells from a small skin sample at the point of care. This technology significantly reduces the need for extensive donor skin harvesting, accelerates healing times, minimizes scarring, and improves overall outcomes for patients suffering from severe thermal burns and full-thickness skin defects.